Gloucestershire Hospitals NHS Foundation Trust
Gloucester, Gloucestershire, GL1 3NN, United Kingdom
NCT Number: NCT03468634
To develop and endoscopic Raman spectroscopy probe for delivery down and channel in an endoscope to make near instant assessments of the condition of the oesophagus without the need for expensive and distressing tissue removal (biopsies).
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Gloucester, Gloucestershire, GL1 3NN, United Kingdom
The investigators have already shown that it is possible to tell the difference between healthy and diseased tissue in the laboratory by looking at the light emitted by tissue when illuminated with a low power laser. The investigators intend to use this technique, known as "Raman Spectroscopy" to tell if tissue in the oesophagus is cancerous, healthy or at some stage before full blown cancer, which is termed pre-cancer. It has been shown in the laboratory that this method will be at least as accurate as the conventional methods used now, but will provide the surgeon with instant results without the delay and cost of a laboratory analysis by pathologists.
A miniature probe has been developed that slides through a channel in the endoscope (telescope) to the surface of the oesophagus to make near instant assessments of its condition without the need for expensive and distressing tissue removal (biopsies). This project plans to move this technique from the laboratory to the clinic by demonstrating that the method is safe and reliable for use in real patients.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Oesophageal endoscopy with biopsy
Other names: EGD (esophagogastro duodenoscopy), upper GI endoscopy
Time frame: 6 months
Testing of the device for clinical application to demonstrate its use is safe and that is able to acquire diagnostic-quality (see outcome 2) spectra in less than 5 seconds from within the oesophagus.
Samples illuminated will be biopsied and sent for routine histopathological analysis.
Time frame: 6 months
Computer model using multivariate analysis able to discriminate between diseased and non-diseased tissue. The target specificity and sensitivity are low due to small study group sizes.
University of Exeter
Other
Acronym: RaPIDE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06381583
Adenocarcinoma Of Esophagus, Barrett Adenocarcinoma
Duarte, California, United States
View Trial DetailsNCT03205501
Barrett Esophagus, Digestive System Diseases
Groningen, Netherlands
View Trial DetailsNCT04656392
Barrett Esophagus, Digestive System Diseases
Nijmegen, Gelderland, Netherlands
View Trial DetailsNCT01447927
Barrett Esophagus, Digestive System Diseases
Hines, Illinois, United States
View Trial Details